PE20061007A1 - Proceso para elaborar lactosa utilizando tecnicas pre-clasificacion y formulaciones farmaceuticas formadas a partir de ella - Google Patents
Proceso para elaborar lactosa utilizando tecnicas pre-clasificacion y formulaciones farmaceuticas formadas a partir de ellaInfo
- Publication number
- PE20061007A1 PE20061007A1 PE2006000159A PE2006000159A PE20061007A1 PE 20061007 A1 PE20061007 A1 PE 20061007A1 PE 2006000159 A PE2006000159 A PE 2006000159A PE 2006000159 A PE2006000159 A PE 2006000159A PE 20061007 A1 PE20061007 A1 PE 20061007A1
- Authority
- PE
- Peru
- Prior art keywords
- lactose
- microns
- particles
- particle size
- pharmaceutical formulations
- Prior art date
Links
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 title abstract 5
- 239000008101 lactose Substances 0.000 title abstract 5
- 238000000034 method Methods 0.000 title abstract 4
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 239000002245 particle Substances 0.000 abstract 7
- 229960001375 lactose Drugs 0.000 abstract 4
- 238000009472 formulation Methods 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- XWTYSIMOBUGWOL-UHFFFAOYSA-N (+-)-Terbutaline Chemical compound CC(C)(C)NCC(O)C1=CC(O)=CC(O)=C1 XWTYSIMOBUGWOL-UHFFFAOYSA-N 0.000 abstract 1
- WSVLPVUVIUVCRA-KPKNDVKVSA-N Alpha-lactose monohydrate Chemical compound O.O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O WSVLPVUVIUVCRA-KPKNDVKVSA-N 0.000 abstract 1
- KUVIULQEHSCUHY-XYWKZLDCSA-N Beclometasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(Cl)[C@@H]1[C@@H]1C[C@H](C)[C@@](C(=O)COC(=O)CC)(OC(=O)CC)[C@@]1(C)C[C@@H]2O KUVIULQEHSCUHY-XYWKZLDCSA-N 0.000 abstract 1
- VOVIALXJUBGFJZ-KWVAZRHASA-N Budesonide Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@@H]2[C@@H]1[C@@H]1C[C@H]3OC(CCC)O[C@@]3(C(=O)CO)[C@@]1(C)C[C@@H]2O VOVIALXJUBGFJZ-KWVAZRHASA-N 0.000 abstract 1
- GIIZNNXWQWCKIB-UHFFFAOYSA-N Serevent Chemical compound C1=C(O)C(CO)=CC(C(O)CNCCCCCCOCCCCC=2C=CC=CC=2)=C1 GIIZNNXWQWCKIB-UHFFFAOYSA-N 0.000 abstract 1
- NDAUXUAQIAJITI-UHFFFAOYSA-N albuterol Chemical compound CC(C)(C)NCC(O)C1=CC=C(O)C(CO)=C1 NDAUXUAQIAJITI-UHFFFAOYSA-N 0.000 abstract 1
- 239000002260 anti-inflammatory agent Substances 0.000 abstract 1
- 229960004495 beclometasone Drugs 0.000 abstract 1
- 229940125388 beta agonist Drugs 0.000 abstract 1
- 229960004436 budesonide Drugs 0.000 abstract 1
- 239000011362 coarse particle Substances 0.000 abstract 1
- 229960002714 fluticasone Drugs 0.000 abstract 1
- MGNNYOODZCAHBA-GQKYHHCASA-N fluticasone Chemical compound C1([C@@H](F)C2)=CC(=O)C=C[C@]1(C)[C@]1(F)[C@@H]2[C@@H]2C[C@@H](C)[C@@](C(=O)SCF)(O)[C@@]2(C)C[C@@H]1O MGNNYOODZCAHBA-GQKYHHCASA-N 0.000 abstract 1
- 229960001021 lactose monohydrate Drugs 0.000 abstract 1
- 229960001664 mometasone Drugs 0.000 abstract 1
- QLIIKPVHVRXHRI-CXSFZGCWSA-N mometasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(Cl)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CCl)(O)[C@@]1(C)C[C@@H]2O QLIIKPVHVRXHRI-CXSFZGCWSA-N 0.000 abstract 1
- 230000000704 physical effect Effects 0.000 abstract 1
- 239000000843 powder Substances 0.000 abstract 1
- 229960002052 salbutamol Drugs 0.000 abstract 1
- 229960004017 salmeterol Drugs 0.000 abstract 1
- 229960000195 terbutaline Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- C—CHEMISTRY; METALLURGY
- C13—SUGAR INDUSTRY
- C13K—SACCHARIDES OBTAINED FROM NATURAL SOURCES OR BY HYDROLYSIS OF NATURALLY OCCURRING DISACCHARIDES, OLIGOSACCHARIDES OR POLYSACCHARIDES
- C13K5/00—Lactose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7016—Disaccharides, e.g. lactose, lactulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H3/00—Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Pulmonology (AREA)
- Otolaryngology (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
SE REFIERE A UN PROCESO PARA FORMAR LACTOSA SELECCIONADA DE LACTOSA ANHIDRA, MONOHIDRATO DE LACTOSA Y COMBINACIONES DE ELLAS CON UNA PLURALIDAD DE PARTICULAS QUE CONTIENEN NO MAS DE 10% PESO/PESO DE PARTICULAS DE LACTOSA CON UN TAMANO PROMEDIO DE PARTICULA EN VOLUMEN DE APROXIMADAMENTE 70 MICRAS O MENOS Y COMPRENDE: A) MOLER LA PLURALIDAD DE PARTICULAS DE LACTOSA PARA PRODUCIR PARTICULAS CON UN TAMANO PROMEDIO DE PARTICULA QUE ABARCA DESDE 50 MICRAS HASTA APROXIMADAMENTE 100 MICRAS; B) CLASIFICAR DICHA PLURALIDAD EN AL MENOS UNA FRACCION FINA QUE TIENE UN TAMANO DE PARTICULA ENTRE 3-50 MICRAS Y OTRA FRACCION GRUESA DE TAMANO DE PARTICULA ENTRE 40-250 MICRAS. LA PLURALIDAD DE PARTICULAS SE OBTIENE A PARTIR DE UN PROCESO DE CRISTALIZACION. SE REFIERE TAMBIEN A UNA FORMULACION FARMACEUTICA EN POLVO PARA INHALACION QUE CONTIENE ADEMAS i) AGONISTAS BETA TALES COMO SALBUTAMOL, TERBUTALINA, SALMETEROL; ii) ESTEROIDE ANTI-INFLAMATORIO TALES COMO MOMETASONA, BECLOMETASONA, BUDESONIDA, FLUTICASONA; ENTRE OTROS. LA FORMULACION OBTENIDA MEJORA LAS PROPIEDADES FISICAS COMO BIODISPONIBILIDAD
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US65175505P | 2005-02-10 | 2005-02-10 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20061007A1 true PE20061007A1 (es) | 2006-11-23 |
Family
ID=36793364
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2006000159A PE20061007A1 (es) | 2005-02-10 | 2006-02-10 | Proceso para elaborar lactosa utilizando tecnicas pre-clasificacion y formulaciones farmaceuticas formadas a partir de ella |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US9365905B2 (es) |
| EP (2) | EP3199164B1 (es) |
| JP (1) | JP5156397B2 (es) |
| KR (1) | KR20070119631A (es) |
| CN (2) | CN104177448A (es) |
| AR (1) | AR053677A1 (es) |
| AU (1) | AU2006212966B2 (es) |
| BR (1) | BRPI0606364A2 (es) |
| CA (1) | CA2597557A1 (es) |
| ES (1) | ES2613391T3 (es) |
| IL (1) | IL184746A0 (es) |
| MX (1) | MX2007009656A (es) |
| NO (2) | NO335308B1 (es) |
| NZ (1) | NZ556709A (es) |
| PE (1) | PE20061007A1 (es) |
| RU (1) | RU2007133547A (es) |
| TW (1) | TW200640471A (es) |
| WO (1) | WO2006086270A1 (es) |
| ZA (1) | ZA200706202B (es) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2008217586A1 (en) * | 2007-02-19 | 2008-08-28 | Cipla Limited | Pharmaceutical combinations of at least two bronchodilators or of a bronchodilator with a corticosteroid |
| US11116721B2 (en) | 2009-02-26 | 2021-09-14 | Glaxo Group Limited | Pharmaceutical formulations comprising 4-{(1R)-2-[(6-{2-[(2,6-dichlorobenzyl)oxy]ethoxy}hexyl)amino]-1-hydroxyethyl}-2-(hydroxymethyl) phenol |
| GB0921075D0 (en) | 2009-12-01 | 2010-01-13 | Glaxo Group Ltd | Novel combination of the therapeutic agents |
| PT2538922T (pt) * | 2010-02-25 | 2016-07-11 | Andi-Ventis Ltd | Formulação de composições para o tratamento de doenças inflamatórias |
| WO2011145109A1 (en) * | 2010-05-20 | 2011-11-24 | Sun Pharma Advanced Research Company Ltd., | Dry powder inhalation composition |
| CN102266560A (zh) * | 2010-06-04 | 2011-12-07 | 北京阜康仁生物制药科技有限公司 | 一种用于治疗气喘的药物组合物 |
| US9210947B2 (en) * | 2012-05-11 | 2015-12-15 | N.V. Nutricia | Infant formulae and their preparations |
| WO2014007766A1 (en) * | 2012-07-05 | 2014-01-09 | Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi | Dry powder inhalers comprising a carrier other than lactose |
| WO2014007771A2 (en) | 2012-07-05 | 2014-01-09 | Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi | Inhalation compositions comprising muscarinic receptor antagonist |
| CN107095875B (zh) * | 2016-02-23 | 2022-03-18 | 天津金耀集团有限公司 | 一种昔奈酸沙美特罗丙酸氟替卡松复方粉吸入剂组合物 |
| WO2024121032A1 (en) * | 2022-12-05 | 2024-06-13 | Astrazeneca Ab | Process for producing lactose crystals, inhalable formulation |
| US12214082B1 (en) * | 2024-05-13 | 2025-02-04 | Leprino Foods Company | One pass spray dried lactose |
Family Cites Families (88)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2856318A (en) * | 1956-05-29 | 1958-10-14 | Foremost Dairies Inc | Lactose product and process of manufacture |
| US3344030A (en) * | 1964-06-15 | 1967-09-26 | American Home Prod | Reinforced directly compressed nongranulated pharmaceutical crystalline lactose tables |
| GB1242211A (en) | 1967-08-08 | 1971-08-11 | Fisons Pharmaceuticals Ltd | Pharmaceutical composition |
| GB1359643A (en) * | 1970-09-28 | 1974-07-10 | Controlled Medications | Controlled release medicament |
| GB1381872A (en) | 1971-06-22 | 1975-01-29 | Fisons Ltd | Pharmaceutical compositions for inhalation |
| US4099983A (en) * | 1977-05-31 | 1978-07-11 | Wittenberg Lester H | Process for preparing high purity lactose |
| GB1571629A (en) | 1977-11-30 | 1980-07-16 | Fisons Ltd | Pharmaceutical compositions containing beclomethasone dipropionate |
| JPS5519237A (en) | 1978-07-27 | 1980-02-09 | Toa Iyakuhin Kogyo Kk | Crystalline lactose with high beta-lactose content and diluent comprising it |
| JPS5571498A (en) | 1978-11-24 | 1980-05-29 | Japan Maize Prod | Production of finely divided sugar |
| NL178015C (nl) | 1978-12-08 | 1986-01-02 | Dmv Campina Bv | Werkwijze ter bereiding van watervrije stabiele lactose. |
| GB2064336B (en) | 1979-12-06 | 1984-03-14 | Glaxo Group Ltd | Device for dispensing medicaments |
| FR2493869A1 (fr) | 1980-11-10 | 1982-05-14 | Fives Cail Babcock | Procede de production de lactose cristallise et installation pour la mise en oeuvre de ce procede |
| ATE23272T1 (de) | 1981-07-08 | 1986-11-15 | Draco Ab | Pulverinhalator. |
| SU1105506A1 (ru) | 1982-04-28 | 1984-07-30 | Ставропольский политехнический институт | Способ получени лактозы |
| US4627432A (en) | 1982-10-08 | 1986-12-09 | Glaxo Group Limited | Devices for administering medicaments to patients |
| US4778054A (en) | 1982-10-08 | 1988-10-18 | Glaxo Group Limited | Pack for administering medicaments to patients |
| GB2169265B (en) | 1982-10-08 | 1987-08-12 | Glaxo Group Ltd | Pack for medicament |
| SU1208078A1 (ru) | 1983-07-21 | 1986-01-30 | Воронежский технологический институт | Способ кристаллизации рафинированной @ -лактозы из раствора |
| SU1227670A1 (ru) | 1984-02-06 | 1986-04-30 | Ставропольский политехнический институт | Способ производства молочного сахара |
| SU1286631A1 (ru) | 1984-07-20 | 1987-01-30 | Ставропольский политехнический институт | Способ производства рафинированного молочного сахара |
| NZ217006A (en) * | 1985-07-30 | 1989-04-26 | Glaxo Group Ltd | Inhaler for finely divided medicament includes plunger to open medicament container |
| SU1337026A1 (ru) | 1985-10-15 | 1987-09-15 | Ленинградский технологический институт холодильной промышленности | Способ кристаллизации сгущенного молока и аппарат дл его осуществлени |
| SU1296581A1 (ru) | 1985-11-19 | 1987-03-15 | Воронежский технологический институт | Аппарат дл кристаллизации лактозы из раствора |
| DD246121A1 (de) | 1986-02-21 | 1987-05-27 | Wissenschaftlich Techn Oekon Z | Verfahren zur gewinnung von laktose |
| NL8600731A (nl) | 1986-03-21 | 1987-10-16 | Dmv Campina Bv | Verbeterde gesproeidroogde lactose en werkwijze ter bereiding ervan. |
| FI78504C (fi) | 1987-10-14 | 1989-08-10 | Valio Meijerien | Foerfarande foer tillvaratagande av laktos ur vassla. |
| GB9001635D0 (en) * | 1990-01-24 | 1990-03-21 | Ganderton David | Aerosol carriers |
| GB9004781D0 (en) * | 1990-03-02 | 1990-04-25 | Glaxo Group Ltd | Device |
| US6536427B2 (en) | 1990-03-02 | 2003-03-25 | Glaxo Group Limited | Inhalation device |
| HU213221B (en) | 1990-03-02 | 1997-03-28 | Glaxo Group Ltd | Inhalation device and medicine packet for device |
| US5362455A (en) | 1990-05-03 | 1994-11-08 | Praxair Technology, Inc. | Draft tube, direct contact cryogenic crystallizer |
| RU1796844C (ru) | 1990-10-02 | 1993-02-23 | Белорусский Научно-Исследовательский И Конструкторско-Технологический Институт Мясной И Молочной Промышленности | Способ сушки молочного сахара |
| RU1787413C (ru) | 1990-12-29 | 1993-01-15 | Всесоюзный научно-исследовательский и конструкторский институт молочной промышленности | Способ производства сухой творожной сыворотки |
| DE4140689B4 (de) | 1991-12-10 | 2007-11-22 | Boehringer Ingelheim Kg | Inhalationspulver und Verfahren zu ihrer Herstellung |
| GB9322014D0 (en) * | 1993-10-26 | 1993-12-15 | Co Ordinated Drug Dev | Improvements in and relating to carrier particles for use in dry powder inhalers |
| GB9404945D0 (en) | 1994-03-15 | 1994-04-27 | Glaxo Group Ltd | Pharmaceutical composition |
| GB9501841D0 (en) | 1995-01-31 | 1995-03-22 | Co Ordinated Drug Dev | Improvements in and relating to carrier particles for use in dry powder inhalers |
| EE03997B1 (et) * | 1995-04-14 | 2003-04-15 | Glaxo Wellcome Inc. | Albuterooli doseeriv inhalaator |
| TR199701168T1 (xx) | 1995-04-14 | 1998-05-21 | Glaxo Wellcome Inc. | Flutikazon Propionat i�in �l��lm�� doz inhaleri. |
| EA000889B1 (ru) * | 1995-04-14 | 2000-06-26 | Глаксо Веллкам Инк. | Дозирующий ингалятор дипропионата беклометазона |
| BR9604977A (pt) * | 1995-04-14 | 1998-06-09 | Glaxo Wellcome Inc | Inalador de dose medida sistema inalador de dose medida e uso do mesmo |
| GB9626263D0 (en) | 1996-12-18 | 1997-02-05 | Innovata Biomed Ltd | Powder inhaler |
| GB9626960D0 (en) | 1996-12-27 | 1997-02-12 | Glaxo Group Ltd | Valve for aerosol container |
| GB9700226D0 (en) * | 1997-01-08 | 1997-02-26 | Glaxo Group Ltd | Inhalation device |
| SE9700135D0 (sv) * | 1997-01-20 | 1997-01-20 | Astra Ab | New formulation |
| US6495167B2 (en) * | 1997-03-20 | 2002-12-17 | Schering Corporation | Preparation of powder agglomerates |
| US6503537B2 (en) * | 1997-03-20 | 2003-01-07 | Schering Corporation | Preparation of powder agglomerates |
| US6129905A (en) * | 1997-04-21 | 2000-10-10 | Aeropharm Technology, Inc. | Aerosol formulations containing a sugar as a dispersant |
| TW533865U (en) * | 1997-06-10 | 2003-05-21 | Glaxo Group Ltd | Dispenser for dispensing medicament and actuation indicating device |
| GB2329939A (en) | 1997-06-26 | 1999-04-07 | Glaxo Group Ltd | Self-lubricating valve stem for aerosol containers |
| GB9806477D0 (en) | 1998-03-26 | 1998-05-27 | Glaxo Group Ltd | Improved crystals |
| JP2002512183A (ja) * | 1998-04-18 | 2002-04-23 | グラクソ グループ リミテッド | 医薬用エアゾール製剤 |
| GB9826783D0 (en) | 1998-12-04 | 1999-01-27 | Scherer Ltd R P | Inhalation powders |
| GB9827145D0 (en) * | 1998-12-09 | 1999-02-03 | Co Ordinated Drug Dev | Improvements in or relating to powders |
| US6390291B1 (en) * | 1998-12-18 | 2002-05-21 | Smithkline Beecham Corporation | Method and package for storing a pressurized container containing a drug |
| GB9828721D0 (en) | 1998-12-24 | 1999-02-17 | Glaxo Group Ltd | Novel apparatus and process |
| AR022695A1 (es) | 1999-01-28 | 2002-09-04 | Schering Corp | PORTADOR SoLIDO PARTICULADO Y MÉTODO PARA PROVEER CONTROL DE LA PARTICULADA PARA LA DISTRIBUCIoN DE TAMANO DE PARTíCULAS Y DE CONTENIDO AMORFO CONVERTIBLE DURANTE SU PREPARACION |
| US6623760B1 (en) * | 1999-01-28 | 2003-09-23 | Schering Corporation | Method of preparing particles for agglomeration |
| IT1309592B1 (it) | 1999-03-05 | 2002-01-24 | Chiesi Farma Spa | Particelle veicolo modificate da utilizzarsi nella preparazione diformulazioni farmaceutiche sotto forma di polimeri per inalazione e |
| ITMI991582A1 (it) | 1999-07-16 | 2001-01-16 | Chiesi Farma Spa | Polveri costituite da particelle aventi la superficie perfettamente levigata da utilizzare come veicoli per la preparazione di miscele inala |
| JP2001151673A (ja) | 1999-09-06 | 2001-06-05 | Nikken Chem Co Ltd | 吸入用粉末製剤の製造方法 |
| JP2001072586A (ja) | 1999-09-06 | 2001-03-21 | Nikken Chem Co Ltd | 吸入用粉末製剤及びその製造方法 |
| GB9925934D0 (en) | 1999-11-03 | 1999-12-29 | Glaxo Group Ltd | Novel apparatus and process |
| US7078057B2 (en) | 1999-12-20 | 2006-07-18 | Kerkhof Nicholas J | Process for producing nanometer particles by fluid bed spray-drying |
| DE19962926A1 (de) | 1999-12-24 | 2001-06-28 | Bayer Ag | Verfahren zur Co-Mahlung von Stoffen und Lactose mittels Strahlmühlen |
| EP1129705A1 (en) | 2000-02-17 | 2001-09-05 | Rijksuniversiteit te Groningen | Powder formulation for inhalation |
| EP1274400A1 (en) | 2000-04-11 | 2003-01-15 | Dura Pharmaceuticals, Inc. | Physically stabilized dry powder formulations |
| PE20011227A1 (es) | 2000-04-17 | 2002-01-07 | Chiesi Farma Spa | Formulaciones farmaceuticas para inhaladores de polvo seco en la forma de aglomerados duros |
| GB0012261D0 (en) | 2000-05-19 | 2000-07-12 | Astrazeneca Ab | Novel process |
| GB0012260D0 (en) | 2000-05-19 | 2000-07-12 | Astrazeneca Ab | Novel composition |
| GB0014851D0 (en) | 2000-06-16 | 2000-08-09 | Glaxo Group Ltd | Novel pharmaceutical formulation |
| DK1913939T3 (en) | 2000-06-27 | 2017-09-18 | Vectura Ltd | Formulations for use in inhalers |
| FI20002177A0 (fi) | 2000-10-02 | 2000-10-02 | Orion Yhtymae Oyj | Uusi yhdistelmä astman hoitoon |
| CN1635870A (zh) | 2000-10-09 | 2005-07-06 | 3M创新有限公司 | 药用气雾剂制剂 |
| UA75375C2 (en) | 2000-10-12 | 2006-04-17 | Boehringer Ingelheim Pharma | Method for producing powdery preparations for inhaling |
| JP3870159B2 (ja) | 2000-10-12 | 2007-01-17 | ベーリンガー インゲルハイム ファルマ ゲゼルシャフト ミット ベシュレンクテル ハフツング ウント コンパニー コマンディトゲゼルシャフト | チオトロピウムを含む新規吸入性粉剤 |
| CA2430318C (en) * | 2000-11-29 | 2009-10-27 | Itoham Foods Inc. | Powder formulation and method for producing the same |
| AUPR217700A0 (en) | 2000-12-19 | 2001-01-25 | Food Science Australia | Methods for purification of lactose |
| GB0107106D0 (en) | 2001-03-21 | 2001-05-09 | Boehringer Ingelheim Pharma | Powder inhaler formulations |
| AU2002333644A1 (en) * | 2001-09-17 | 2003-04-01 | Glaxo Group Limited | Dry powder medicament formulations |
| EP1498116A1 (en) | 2002-03-20 | 2005-01-19 | Hosokawa Micron Corporation | Method of manufacturing chemical-containing composite particles |
| GB0208609D0 (en) | 2002-04-13 | 2002-05-22 | Glaxo Group Ltd | Compositions |
| GB0208608D0 (en) | 2002-04-13 | 2002-05-22 | Glaxo Group Ltd | Composition |
| JP2003313118A (ja) | 2002-04-19 | 2003-11-06 | Fuji Paudal Co Ltd | 造粒物および製造法 |
| DE10218110A1 (de) | 2002-04-23 | 2003-11-20 | Jenapharm Gmbh | Verfahren zum Herstellen von Kristallen von Arzneimittelhilfsstoffen, danach erhältliche Kristalle und deren Verwendung in pharmazeutischen Formulierungen |
| MXPA05001903A (es) * | 2002-08-21 | 2005-04-28 | Norton Healthcare Ltd | Composicion para inhalacion. |
| GB0219513D0 (en) | 2002-08-21 | 2002-10-02 | Norton Healthcare Ltd | Inhalation compositions including coarse carrier |
| GB0228826D0 (en) | 2002-12-11 | 2003-01-15 | Okpala Joseph | Hair technology in creating particles with improved delivery capabilities |
-
2006
- 2006-02-06 ES ES06734392.1T patent/ES2613391T3/es active Active
- 2006-02-06 WO PCT/US2006/004032 patent/WO2006086270A1/en not_active Ceased
- 2006-02-06 JP JP2007555148A patent/JP5156397B2/ja active Active
- 2006-02-06 US US11/815,890 patent/US9365905B2/en active Active
- 2006-02-06 RU RU2007133547/15A patent/RU2007133547A/ru not_active Application Discontinuation
- 2006-02-06 KR KR1020077020666A patent/KR20070119631A/ko not_active Ceased
- 2006-02-06 BR BRPI0606364-0A patent/BRPI0606364A2/pt not_active IP Right Cessation
- 2006-02-06 CN CN201410210363.8A patent/CN104177448A/zh active Pending
- 2006-02-06 CA CA002597557A patent/CA2597557A1/en not_active Abandoned
- 2006-02-06 EP EP16191843.8A patent/EP3199164B1/en active Active
- 2006-02-06 MX MX2007009656A patent/MX2007009656A/es not_active Application Discontinuation
- 2006-02-06 AU AU2006212966A patent/AU2006212966B2/en active Active
- 2006-02-06 CN CNA2006800115831A patent/CN101155590A/zh active Pending
- 2006-02-06 EP EP06734392.1A patent/EP1848444B1/en active Active
- 2006-02-06 NZ NZ556709A patent/NZ556709A/en unknown
- 2006-02-10 TW TW095104612A patent/TW200640471A/zh unknown
- 2006-02-10 PE PE2006000159A patent/PE20061007A1/es not_active Application Discontinuation
- 2006-02-10 AR ARP060100486A patent/AR053677A1/es not_active Application Discontinuation
-
2007
- 2007-07-19 IL IL184746A patent/IL184746A0/en active IP Right Grant
- 2007-07-20 NO NO20073793A patent/NO335308B1/no unknown
- 2007-07-26 ZA ZA200706202A patent/ZA200706202B/xx unknown
-
2014
- 2014-03-11 NO NO20140310A patent/NO20140310L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CA2597557A1 (en) | 2006-08-17 |
| TW200640471A (en) | 2006-12-01 |
| EP1848444A4 (en) | 2012-12-12 |
| BRPI0606364A2 (pt) | 2010-03-23 |
| NO20073793L (no) | 2007-11-07 |
| ES2613391T3 (es) | 2017-05-24 |
| MX2007009656A (es) | 2007-11-07 |
| EP3199164B1 (en) | 2020-03-18 |
| AU2006212966A1 (en) | 2006-08-17 |
| CN104177448A (zh) | 2014-12-03 |
| IL184746A0 (en) | 2007-12-03 |
| ZA200706202B (en) | 2008-10-29 |
| JP2008530093A (ja) | 2008-08-07 |
| EP1848444B1 (en) | 2016-11-09 |
| CN101155590A (zh) | 2008-04-02 |
| EP1848444A1 (en) | 2007-10-31 |
| US9365905B2 (en) | 2016-06-14 |
| KR20070119631A (ko) | 2007-12-20 |
| AU2006212966B2 (en) | 2008-09-11 |
| NO20140310L (no) | 2007-11-07 |
| EP3199164A1 (en) | 2017-08-02 |
| JP5156397B2 (ja) | 2013-03-06 |
| US20090047351A1 (en) | 2009-02-19 |
| AR053677A1 (es) | 2007-05-16 |
| NZ556709A (en) | 2009-09-25 |
| NO335308B1 (no) | 2014-11-10 |
| RU2007133547A (ru) | 2009-03-20 |
| WO2006086270A1 (en) | 2006-08-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE20061007A1 (es) | Proceso para elaborar lactosa utilizando tecnicas pre-clasificacion y formulaciones farmaceuticas formadas a partir de ella | |
| EA201070162A1 (ru) | Лекарственное средство в виде сухого порошка | |
| Liu et al. | Traditional uses, chemical diversity and biological activities of Panax L.(Araliaceae): A review | |
| AR129501A2 (es) | FORMULACIÓN EN POLVO SECO QUE COMPRENDE UN ANTICOLINÉRGICO, UN CORTICOSTEROIDE Y UN b-ADRENÉRGICO PARA ADMINISTRAR POR INHALACIÓN | |
| PE20011227A1 (es) | Formulaciones farmaceuticas para inhaladores de polvo seco en la forma de aglomerados duros | |
| WO2009050726A3 (en) | Compositions and methods for improved delivery of bupropion | |
| PE20030949A1 (es) | Formulaciones en aerosol para la administracion pulmonar de medicamentos que producen un efecto sistemico | |
| Jones et al. | An investigation into the dispersion mechanisms of ternary dry powder inhaler formulations by the quantification of interparticulate forces | |
| WO2017049245A3 (en) | Compounds and compositions for intracellular delivery of therapeutic agents | |
| Saleem et al. | Micronization of a soft material: air-jet and micro-ball milling | |
| AR085120A1 (es) | Formulaciones de particulas en polvo seco que contienen dos o mas ingredientes activos para el tratamiento de las enfermedades obstructivas o inflamatorias de las vias respiratorias | |
| EA201000752A1 (ru) | Фармацевтическая композиция, содержащая эзетимиб | |
| MX2023006856A (es) | Composiciones de polvo seco con estearato de magnesio. | |
| BR112013022431A2 (pt) | derivado de polissacarídeo, forma de dosagem, processo para preparar uma forma de dosagem e uso de um derivado de polissacarídeo | |
| FI3500241T3 (fi) | Yhdistelmähoito copd:lle | |
| BR112015020443A2 (pt) | desamorfização de formulações secadas por atomização via mistura por atomização | |
| MX2017004476A (es) | Composicion que comprende al menos un polvo seco obtenido por secado por atomizacion para aumentar la estabilidad de la formulacion. | |
| PE20061203A1 (es) | Combinacion de xolair con agente inmunosupresor | |
| CN1658884A (zh) | 二水合脱氢表雄酮和采用其组合物治疗哮喘或慢性阻塞性肺部疾病的方法 | |
| PE20120422A1 (es) | Formulaciones orales solidas de (r)-2-amino-7-[4-fluoro-2-(6-metoxi-piridin-2-il)-fenil]-4-metil-7,8-dihidro-6h-pirido-[4,3-d]-pirimidin-5-ona | |
| AR043579A1 (es) | Procedimiento para la preparacion de ciclesonida cristalina con un tamano definido de particulas | |
| Lee et al. | Anti-cancer activity of the ethylacetate fraction from Orostachys japonicus for modulation of the signaling pathway in HepG2 human hepatoma cells | |
| ES2422433T3 (es) | Procedimiento para la preparación de partículas esféricas a partir de una sustancia farmacéutica | |
| WO2011101114A3 (en) | An inhalable pharmaceutical composition | |
| ES2662847T3 (es) | Formulaciones novedosas de inhalación |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |